"This really provides an opportunity for a physician to wait and do nothing."

— Anthony Curcio, CEO of VasSol (Chicago) on how the company's NOVA (Non-invasive Optimal Vessel Analysis) system allows physicians to non-invasively quantify the volumetric blood flow rate in vessels, "VasSol says test 1st to assess vascular volumetric blood flow," pp. 1, 8